Alzheimer's disease, a progressive neurological disorder, primarily affects memory, thinking skills, and behavior. While there is no cure, several drugs aim to manage symptoms and slow cognitive decline. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are commonly prescribed to enhance communication among brain cells by increasing levels of acetylcholine, a neurotransmitter crucial for memory and learning. Another class of drugs, NMDA receptor antagonists like memantine, regulates glutamate activity to protect brain cells from excess damage, offering symptom relief in moderate to severe Alzheimer's cases. These medications may help maintain quality of life and independence for some individuals, although their effectiveness varies and they do not halt disease progression. Ongoing research seeks more effective treatments and strategies to combat this challenging condition.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China